Mabala, Judith S.
HRN: 21-51-22 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/26/2022
CEFUROXIME 500MG (TAB)
06/26/2022
07/02/2022
ORAL
500mg
BID
RMLE With Repair Of Perineal Laceration
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes